G. Perrocheau
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
- Neutropenia and Cancer Infections
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 2
- Co-authors
- P. FumoleauR. FétyAgnès HardouinP PouillartL. KayitalireVéronique DièrasSalima KallaMuriel Barberi‐Heyob
- Journals
- Journal of Clinical Oncology (4 papers)Oncology (3 papers)European Journal of Cancer (2 papers)Frontiers in Oncology (1 paper)Radiotherapy and Oncology (1 paper)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
G. Perrocheau
17 papers receiving 333 citations
Peers
Comparison fields: 5 of 52
- Oncology 282
- Cancer Research 72
- Dermatology 36
- Pulmonary and Respiratory Medicine 84
- Genetics 19
Countries citing papers authored by G. Perrocheau
This map shows the geographic impact of G. Perrocheau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Perrocheau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Perrocheau more than expected).
Fields of papers citing papers by G. Perrocheau
This network shows the impact of papers produced by G. Perrocheau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Perrocheau. The network helps show where G. Perrocheau may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Perrocheau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 9 | |
| 3 | 2017 | 2 | |
| 4 | 2010 | 20 | |
| 5 | 2008 | 5 | |
| 6 | 2007 | 18 | |
| 7 | 2007 | 2 | |
| 8 | 2007 | 7 | |
| 9 | 2007 | 1 | |
| 10 | 2006 | 2 | |
| 11 | 2001 | 20 | |
| 12 | 2001 | 122 | |
| 13 | Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas. | 1998 | 96 |
| 14 | 1997 | 3 | |
| 15 | Docetaxel combined with vinorelbine: phase I results and new study designs. | 1997 | 23 |
| 16 | [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy]. | 1995 | 6 |
| 17 | 1995 | 2 |
About G. Perrocheau
G. Perrocheau is a scholar working on Oncology, Occupational Therapy, Radiation, Dermatology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (6 papers), Economic and Financial Impacts of Cancer (4 papers), Medical Imaging Techniques and Applications (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Breast Cancer Treatment Studies (2 papers), Radiation Dose and Imaging (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (282 citations), Cancer Research (72 citations), Dermatology (36 citations), Pulmonary and Respiratory Medicine (84 citations) and Genetics (19 citations). G. Perrocheau has collaborated with scholars based in France, Canada and United States. Frequent co-authors include P. Fumoleau, R. Féty, Agnès Hardouin, P Pouillart, L. Kayitalire, Véronique Dièras, Salima Kalla, Muriel Barberi‐Heyob, C. Cuvier and Jean‐Louis Merlin. Their work appears in journals such as Journal of Clinical Oncology, Oncology, European Journal of Cancer, Frontiers in Oncology and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.